Meta Pixel

News and Announcements

How An MVP Can Become Your Startup’s Gateway To Success

  • Published December 14, 2022 4:52AM UTC
  • Publisher Osama Hassan
  • Categories Capital Raising Tips

These should be the immediate goals of a pre-launch startup:

1 – Launch quickly (get your market viable product (MVP) ready)

2 – Get initial users (traction)

3 – Talk to users and get feedback (establish market proof)

4 – Iterate (keep developing)

And it all begins with getting an MVP ready.

You may ask, what is an MVP?

Think about it this way: it’s something ridiculously simple, which is the very first thing you give to the very first set of users you want to target, in order to see if you can deliver any value at all.

Easy!

In most industries (medtech and biotech are exceptions) getting an MVP ready should not be super difficult.

In most cases, you can get a lean MVP ready in a few weeks. Though it may have limited functionalities and might only appeal to a small set of users, it gives founders the base to iterate (and develop further) from.

To quote Y Combinator‘s CEO Michael Seibel:

“Hold the problem you’re solving tightly, hold your customer tightly, but hold the solution you’re building loosely.”

For budding entrepreneurs, before thinking of raising capital and approaching investors, make sure you’ve got some kind of an MVP ready, some traction and some evidence of market proof.

Trust me, it will help and really demonstrate initiative to investors.

✌️

Click here to view the original Linkedin post.

Looking for a platform to raise capital? Click here to discover how Wholesale Investor can help you.

Your capital engagement platform

With a 14-year track record, a network of 32,000+ investors, and a capital raising platform, Wholesale investor is a leading investment platform for start-ups, scale-ups, emerging growth companies, and small caps.

Capital Insights
The Ferrari of Immunotherapy: Chimeric’s High-Stakes Race to Cure Cancer

In the high-stakes world of biotechnology, the most sophisticated weapon against cancer isn’t a new chemical compound but the patient’s own immune system, re-engineered with the precision of a high-performance engine. “This particular CAR T is like a Ferrari,” says Dr. Rebecca McQualter, CEO of Chimeric Therapeutics (ASX: CHM). “It’s got two big engines on […]

Capital Insights
From Algae Pioneers to a Natural Revolution: The Second Act of WRS Bioproducts

As the US FDA prepares to phase out synthetic food colors by the end of 2026, WRS Bioproducts is stepping in to solve a looming supply crisis. Led by industry pioneer Harry Rosen, the company is leveraging 40 years of industrial algae farming expertise to scale production of natural, superior-quality beta-carotene, positioning itself as a vital supplier in the rapidly shifting global market for natural ingredients.

Join over 45,000+ sophisticated investors

Join Now